As its name implies, pseudogout has many of the same symptoms as gout, including the sudden onset of severe pain, swelling, warmth, and redness in a joint.

See All About Gout - Symptoms, Diagnosis, Treatment

Pseudogout most frequently affects the knee but can occur in any joint, including the ankle, wrist, shoulder, elbow, and hip. Unlike gout, however, pseudogout rarely affects the big toe.1

Joint fluid analysis is the most dependable way to diagnose pseudogout.

Pseudogout occurs when calcium pyrophosphate crystals accumulate in a joint and trigger an immune system response. Doctors often refer to pseudogout as calcium pyrophosphate deposition (CPPD) or acute calcium pyrophosphate crystal arthritis (acute CPP crystal arthritis).

See What Is Calcium Pyrophosphate Crystals Deposition (CPPD)?

The crystals that cause pseudogout are frequently found in the joints of older people, but only occasionally do the crystals trigger pseudogout episodes. In fact, one clinical study found that more than half the subjects undergoing total knee arthroplasty had evidence of calcium pyrophosphate crystal deposits in their joint tissue, and that almost none of the subjects who had the crystals were aware of them.2

Pseudogout is less common than gout and osteoarthritis, and it is often misdiagnosed as gout, osteoarthritis or rheumatoid arthritis. Thankfully, the initial treatments for these conditions are quite similar, so a misdiagnosis does not necessarily result in the wrong treatment.


What Is Pseudogout?

Doctors sometimes refer to pseudogout and gout as "crystal-induced arthropathies," which simply means they are joint diseases caused by microscopic crystals. The primary difference between these two diseases is the type of crystals that cause symptoms:

  • Pseudogout is caused by calcium pyrophosphate dihydrate crystals, often referred to as calcium pyrophosphate crystals or CPP crystals.
  • Gout is caused by monosodium urate crystals, often referred to as uric acid crystals.

In This Article:

Experts believe calcium pyrophosphate crystals are produced in a joint's cartilage, and if the cartilage is disturbed through normal wear-and-tear, an injury or trauma, the crystals can be released into the joint fluid and other nearby soft tissue. This in turn can trigger an acute immune response resulting in a brief episode of severe pain, swelling, redness, and warmth called pseudogout or CPPD.

See What Is Cartilage?

Researchers have known about calcium pyrophosphate crystals for decades but still do not fully understand the crystals' exact origins, or why some people who have them experience pseudogout episodes and others do not. There is also a lack of reliable studies regarding the number of people who get pseudogout , although it is known that the risk increases exponentially with age.3,4


Left untreated, an initial pseudogout episode will usually resolve itself within 5 to 14 days.3,5 Successive episodes may last longer and may affect more joints. Repeated instances of pseudogout inflammation can permanently damage joints over time. This damage is diagnosed as "secondary" osteoarthritis.

Research suggests people who have osteoarthritis are up to three times more likely to have calcium pyrophosphate crystal deposits than those who do not.6 Whether the crystals cause joint damage or are the result of joint damage - or both - has long been debated. Scientists agree more research needs to be done in this area.4,7


  • 1.Musculoskeletal Network, Journal of Musculoskeletal Medicine. Emkey GR and Reginato AM. October 16, 2009. All about gout and pseudogout: Meeting a growing challenge.
  • 2.Viriyavejkul P, Wilairatana V, Tanavalee A, Jaovisidha K. Comparison of characteristics of patients with and without calcium pyrophosphate dihydrate crystal deposition disease who underwent total knee replacement surgery for osteoarthritis. Osteoarthritis Cartilage. 2007 Feb;15(2):232-5. Epub 2006 Oct 10. PubMed PMID: 17045495.
  • 3.Cleveland Clinics. Disease Management Project: Gout and Pseudogout. ©2000-2010. Accessed May 24, 2012.
  • 4.Zhang et al. European League Against Rheumatism recommendations for calcium pyrophosphate deposition. Part I. Ann Rheum Dis. 2011 Apr;70(4):563-70. Epub 2011 Jan 7. PubMed PMID: 21216817.
  • 5.Ivory D, Velázquez CR. The forgotten crystal arthritis: calcium pyrophosphate deposition. Mo Med. 2012 Jan-Feb;109(1):64-8. Review. PubMed PMID: 22428450.
  • 6.Nalbant S., Martinez JAM, Kitumnuaypong T, Clayburne G, Sieck M, Schumacher HR. Synovial fluid features and their relations to osteoarthritis severity: new findings from sequential studies. Osteoarthritis and Cartilage 11, 50-54 (2003).
  • 7.American College of Rheumatology. Pseudogout (Calcium Pyrophosphate Deposition Disease). Patient fact sheet, updated July 2011. Accessed on May 10, 2012.